Skip to main content
Duke 100 Centennial logo
Home
  • About
    • Mission
    • Founder
    • Advisory Board
    • Partners & Funders
    • Research Independence
    • Contact
  • Careers
  • Resource Portal
  • Contact
  • People
    • Leadership
    • Faculty
    • Research Team
    • Operations Team
    • Education Team
    • Visiting Fellows
    • Margolis Scholars
    • Margolis Interns
    • Find an Expert
  • Research & Policy

    Focus Areas

    • Health Care Transformation
    • Biomedical Innovation
    • 21st Century Public Health
    • Education & Workforce Development

    Topics

    • Federal Health Care Transformation
    • State Health Care Transformation and Medicaid Transformation
    • Digital Health & AI
    • Medical Product Payment, Pricing, and Coverage
    More topics

    Publications

    • Case Studies
    • Journal Articles
    • Policy Briefs
    • Student Publications
    • White Papers
    • Op-Eds/Commentaries
    All publications

    Policy/Perspectives

    • Op-Eds/Commentaries
  • Education

    Focus Areas

    • Undergraduate Students
    • Graduate & Professional Students
    • Continuing Education

    Core Offerings

    • Undergraduate Health Policy Certificate
    • Duke-Margolis Postdoctoral & Affiliated Fellows Program
    • Health Policy Courses
    • Margolis Scholars Program
    • Margolis Internship Program
    • Summer Research Showcase
    • Margolis/Bass Connections Open Theme
    • Career Resources and Opportunities
    • Health Equity Education

    Get Involved

    • Student Voices
    • Margolis Seminars
    • Point of Care Speaker Series
    • Stay Informed - Margolis Newsletter
    • Student Collaborative on Health Policy (SCOHP)
    • Duke Fuqua MBA Health Care Club (HCC)
  • News

    News

    • Duke-Margolis News
  • Events

    Events

    • COVID-19 Related Webinars
    • Margolis Seminars
    • Health Policy Talks
    • All Duke-Margolis Events
  • Give

Breadcrumb

  1. Home
  2. Publications
  3. Monoclonal Antibody Therapies: High-Risk Settings

Monoclonal Antibody Therapies: High-Risk Settings

Monoclonal Antibody Therapies: High-Risk Settings

Published date

February 16, 2021

Topics

COVID-19 Response
View Publication (PDF)
  • People
  • Research
  • Education
  • News
  • Events
  • Give
  • About
  • Careers
  • Resource Portal
  • Contact Us

Contact

If you or your organization are interested in partnering with us, you can contact us.

Duke University logo

  • Connect

Duke University logo